Skip to Main Content

Pulmonary, Critical Care & Sleep Medicine

At Yale Medicine, our pulmonary, critical care, and sleep medicine physicians focus on your respiratory health. We have a team of specialists to diagnose, treat, and manage respiratory conditions that affect your lungs and breathing. From asthma to complex lung diseases, our goal is to help you breathe easier.

Our doctors are board-certified in internal medicine, pulmonary medicine, critical care, and sleep medicine. These expert physicians work closely with specialists in cardiology, diagnostic radiology, and pathology to provide you with comprehensive care for your respiratory condition. Office visits take place at the Winchester Center for Lung Disease in North Haven, Connecticut. Our sleep specialists treat most types of sleep disorders and see patients at our sleep centers at 3 locations in New Haven County.

Our Services

Specialized care is offered in the following areas:

  • Adult cystic fibrosis
  • Asthma and airway diseases
  • Bronchiectasis and chronic pulmonary infections
  • Cardiorespiratory exercise testing
  • Chronic obstructive pulmonary disease (COPD)
  • Clinical research in a wide range of lung diseases
  • Interstitial lung disease
  • Lung cancer screening and pulmonary nodule evaluation
  • Medical intensive care unit for pulmonary conditions
  • Multidisciplinary sleep care
  • Pulmonary embolism
  • Pulmonary function laboratory
  • Pulmonary vascular disease
  • Sleep apnea and other sleep disorders
  • Thoracic interventional pulmonary embolism
  • Thoracic oncology
  • Tuberculosis

Distinguishing Factors

  • Our Center for Pulmonary Medicine (P2MED) focuses on developing methods to apply precision medicine approaches to chronic lung disease.
  • Our Interstitial Lung Disease Center is a Pulmonary Fibrosis Foundation-recognized clinical care center, one of the first nine in the United States.
  • Our Thoracic Interventional Program offers the most advanced diagnostic and therapeutic approaches to diseases of the chest, including lung nodules and masses, enlarged lymph nodes, complex airways, and pleural effusions.
  • Our Pulmonary Vascular Disease Program is recognized by PH and Scleroderma Foundation.
  • We conduct clinical trials and observational studies in asthma, idiopathic pulmonary fibrosis, pulmonary hypertension, and sarcoidosis.
  • We have support groups and outreach activities for idiopathic pulmonary fibrosis and cystic fibrosis.

News

Showing 3 of 29
Source: CCM